Edwards Lifesciences Corporation
NYQ: EWLive Quote
📈 ZcoreAI Score
Our AI model analyzes Edwards Lifesciences Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get EW Z-Score →About Edwards Lifesciences Corporation
Healthcare
Medical Devices
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
📊 Fundamental Analysis
Edwards Lifesciences Corporation demonstrates a healthy profit margin of 17.7%.
The company recently reported 13.3% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 10.4%, which suggests room for improvement in capital utilization.
At a current price of $77.87, EW currently sits at the 48th percentile of its 52-week range (Range: $68.63 - $87.89).
💰 Valuation Insight
EW trades at a 72.1% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
⚠️
Profit Margin
Moderate
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$45.23B
Trailing P/E
43.02
Forward P/E
23.45
Beta (5Y)
0.94
52W High
$87.89
52W Low
$68.63
Avg Volume
4.69M
Day High
Day Low